Overview
- 4 inspections across 4 sites are on record.
- 141 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2018-11-09.
At a glance
Inspections
4
Sites
4
Observations
141
Career since
Oct 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Pharmaceutics International, Inc. | 9 Nov 2018 | Human Drugs | View 483 → |
| Pharmaceutics International, Inc. | 9 Nov 2018 | Human Drugs | View 483 → |
| Mylan Pharmaceuticals Inc | 12 Apr 2018 | Human Drugs | View 483 → |
| Medical Products Laboratories, Inc. | 12 Oct 2017 | Medical Devices & Rad Health | View 483 → |
Sites inspected
Pharmaceutics International, Inc.Hunt Valley, United States1 insp.
Pharmaceutics International, Inc.Cockeysville, United States1 insp.
Mylan Pharmaceuticals IncMorgantown, United States1 insp.
Medical Products Laboratories, Inc.Philadelphia, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Alice S Tsao2 shared
Simone E Pitts2 shared
Michael Shanks2 shared
David A Oluwo2 shared
Atul Agrawal1 shared
Ko U Min1 shared
Rebecca E Dombrowski1 shared
Ileana Barreto-Pettit1 shared
Marcus A Ray1 shared
James M Simpson1 shared
Full investigator report
Get the verbatim findings behind Alison N Stieg's 141 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site